July 26, 2023

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

Geneyx

Originally Posted by:Geneyx

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

 

26/07/2023 – Herzlia, Israel: Geneyx, a leading genomic analysis company, and Ocean Genomics announced they were awarded a grant from the BIRD Foundation to develop a cutting-edge MultiOmic software method. This joint effort combine’s DNA and RNA technologies, revolutionizing the detection of genomic variants, advancing disease diagnosis and drug target identification.

This will have far-reaching implications for personalized medicine, allowing for the identification of drug targets and tailored treatment plans. 

 

“We are thrilled to receive the grant from the Bird Foundation and collaborate with Ocean Genomics on this groundbreaking project. Integrating DNA and RNA technologies to create a MultiOmic software method holds tremendous potential for improving disease diagnosis and identifying drug targets. This advancement will pave the way for personalized medicine, enabling us to develop tailored treatment plans based on individual genetic profiles.”

David Yizhar, CEO of Geneyx 

“Many diseases are caused by structural variants, but they can be difficult to detect, and many are missed in testing only DNA or RNA alone. By deeply integrated analysis of a patient’s DNA and RNA together, we can identify more of these variants, improve diagnosis, and determine targets for new therapies.  Many thanks to the BIRD Foundation for recognizing the importance of this innovation and supporting us to develop and bring these this solution to market in collaboration with Geneyx.”

Carl Kingsford, CEO Ocean Genomics

“Congratulations to Geneyx and Ocean Genomics on receiving the grant from the BIRD Foundation to support their joint project. Their innovative MultiOmic software technique has the potential to revolutionize the field of genomics and significantly contribute to the diagnosis of diseases and identification of drug targets.”

Jaron Lotan, Executive Director of the BIRD Foundation


About Ocean Genomics: Ocean Genomics provides a data and AI platform for advancing drug discovery though the integration of transcriptomic information. Its Intelligent Transcriptome™ hosts over 100,000 transcriptomic samples, many pre-trained models, and a vast and growing molecular knowledge graph. The Intelligent Transcriptome™ enables biopharma partners to discover new targets, signatures, and biomarkers, determine biological impact and MoA, and enable drug rescue and repurposing.

About The BIRD Foundation: A renowned organization dedicated to promoting collaboration and innovation between Israeli and American companies in various industries. It provides grants and funding opportunities to support joint research and development projects, fostering technological advancements and business partnerships. With a focus on promoting cross-border cooperation, the BIRD Foundation plays a crucial role in driving economic growth and knowledge exchange between Israel and the United States.

 

View all our latest news here

Additional Articles

News

Geneyx Among the World's Best Digital Health Companies in 2024

May 15, 2024

Geneyx Among the World’s Best Digital Health Companies in 2024

Newsweek

This acknowledgment highlights Geneyx's significant contributions to the rapidly expanding digital health sector.

Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

March 13, 2024

Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

PR Newswire

Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis.

PacBio Geneyx Press Release

November 1, 2023

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partner Geneyx to PacBio Compatible

PacBio

Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

Geneyx

Geneyx and Ocean Genomics develop a multiomic software method, combining DNA and RNA.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

BIRD Foundation invests $8 million in 9 new projects

James Spiro

Geneyx and Ocean Genomics will develop a multiomic software method, combining DNA and RNA.

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

June 21, 2023

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

Neil Versel

This month's announcement that Oxford Nanopore Technologies would integrate its Epi2Me cloud-based analysis platform with Geneyx's software to automate analysis and clinical reporting of long-read sequencing data

Previous
Next
Geneyx Among the World's Best Digital Health Companies in 2024

May 15, 2024

Geneyx Among the World’s Best Digital Health Companies in 2024

Newsweek

This acknowledgment highlights Geneyx's significant contributions to the rapidly expanding digital health sector.

Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

March 13, 2024

Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

PR Newswire

Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis.

PacBio Geneyx Press Release

November 1, 2023

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partner Geneyx to PacBio Compatible

PacBio

Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

Geneyx

Geneyx and Ocean Genomics develop a multiomic software method, combining DNA and RNA.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

BIRD Foundation invests $8 million in 9 new projects

James Spiro

Geneyx and Ocean Genomics will develop a multiomic software method, combining DNA and RNA.

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

June 21, 2023

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

Neil Versel

This month's announcement that Oxford Nanopore Technologies would integrate its Epi2Me cloud-based analysis platform with Geneyx's software to automate analysis and clinical reporting of long-read sequencing data

+

Selected Videos

Geneyx Analysis Version 5.12 Release

Previous
Next

Schedule Demo

Contact us to set a live demo


Contact Us

Whether you have general questions about our solutions or would like to schedule a demo or to suggest collaboration – our team is on hand for you.